Skip to main content

FDA Registration Assistance

FDA Hand Sanitizer Registration Listing
Drugs · Hand Sanitizer Registration & Listing
Last updated:

FDA Hand Sanitizer Registration & Listing

Hand sanitizer is an OTC drug, so getting it to market is a drug registration-and-listing workflow — three SPL submissions in sequence. First, establishment registration for the manufacturing facility (with DUNS/FEI under 21 CFR Part 207, plus a U.S. Agent if foreign). Second, a labeler code, which becomes the first segment of your NDC. Third, the NDC product listing — the SPL for the specific product, with its active ingredient and strength, dosage form, package, and Drug Facts labeling. Each is validated by FDA, and the listing depends on the registration and labeler code being in place first. On top of the workflow: cGMP, OMUFA fees, and annual renewal. (For why hand sanitizer is a drug and which actives are allowed, see our does hand sanitizer require FDA registration guide.)

The three SPL submissions, the order that matters, what each one contains, and how to keep the listing from being rejected.

Key Takeaways

  • It's a 3-submission workflow — establishment registration, labeler code, product listing.
  • Order matters — the listing rides on the registration + labeler code.
  • Each is an SPL file — validated by FDA (accepted, or returned with errors).
  • The listing carries the product data — active/strength, Drug Facts, package, NDC.
  • Plus cGMP, OMUFA & annual renewal — the workflow includes maintenance.
  • Why it's a drug & which actives — covered on the companion classification page.
The Workflow

Three SPL Submissions, In Order

#SubmissionWhat it does / contains
1Establishment registrationRegisters the facility — DUNS/FEI, operations, and (foreign) the U.S. Agent
2Labeler code formRequests the labeler code — the first segment of your NDC
3Product listingLists the specific hand sanitizer — NDC, active & strength, dosage form, package, Drug Facts labeling
They build on each other: the listing (step 3) references the establishment (step 1) and the labeler code (step 2). Each is a Structured Product Labeling (SPL) file submitted electronically and validated by FDA. See drug registration & listing for the underlying detail.
Step 3, Up Close

What the Product Listing Contains

  • NDC & package configuration — built on your labeler code
  • Active ingredient & strength — e.g., "Ethyl alcohol 70% v/v," with its unique ingredient identifier
  • Dosage form & route — coded to FDA's controlled vocabularies
  • Inactive ingredients
  • Content of labeling — the Drug Facts panel and a labeling image, matching the physical label
The listing's active must be a monograph-eligible one — for hand sanitizer that means ethanol, isopropyl alcohol, or benzalkonium chloride (the eligible-ingredient rules are on the classification page). Here, the point is the listing has to declare a compliant active at a permitted strength.
The Dependency

Why Sequence Is Everything

The most common way a hand sanitizer listing fails is skipping the order. The product listing references your establishment (by DUNS/FEI) and your labeler code (the NDC's first segment) — so both must exist and be active before the listing will validate.

  • Register the establishment first — the listing points to it
  • Get the labeler code assigned — the NDC is built on it
  • Keep the DUNS consistent — the same 9-digit number across labeler code and listing
  • Confirm the U.S. Agent (foreign) — a valid registration underpins the listing
If a listing gets rejected, FDA's validation acknowledgment names the errors — usually a labeler-code/DUNS mismatch, an unregistered establishment, structured-data or labeling issues. Fix them all, re-validate, and resubmit. See FDA drug listing rejected — what to do next.
Around the Workflow

Label, Fees & Keeping It Active

  • Drug Facts label (21 CFR 201.66) — active/strength, purpose, use, warnings (flammable, external use only, do not ingest), directions; must match the SPL listing
  • cGMP (21 CFR 210/211) — including testing to rule out methanol and other contaminants
  • OMUFA — the annual OTC monograph facility fee applies
  • Annual renewal — registration renews October–December (21 CFR 207.29); a lapse can inactivate the listing
Registration and listing are never FDA "approval" — claiming "FDA-approved" because you're registered/listed is misbranding. For the full OTC pathway, see how to register an OTC drug.
Validated on the First Pass

Register & List Your Hand Sanitizer

FDA Registration Assistance runs the whole workflow — establishment registration (with U.S. Agent for foreign firms), the labeler code, and the NDC product listing in SPL, with the active/strength, Drug Facts label, and package data coded correctly so it validates — plus cGMP and OMUFA guidance and annual renewal. If a prior listing was rejected, we diagnose and fix it.

Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.

FAQ

Frequently Asked Questions — Hand Sanitizer Registration & Listing

1. What does "registration and listing" mean for hand sanitizer?

Because hand sanitizer is an OTC drug, getting it to market is a drug registration-and-listing workflow made of three SPL (Structured Product Labeling) submissions: (1) establishment registration for the manufacturing facility; (2) a labeler code, which becomes the first segment of your NDC; and (3) the product listing, which registers the specific product with its NDC. Each is submitted electronically and validated by FDA. Registration identifies the facility; listing identifies the product.

2. Is hand sanitizer actually a drug?

Yes - it's regulated as an OTC drug (a topical consumer antiseptic rub) because "kills germs / reduces bacteria" is a drug claim, not a cosmetic one. That's why the registration-and-listing workflow applies at all. If you want the full explanation of why it's a drug, which active ingredients are eligible, and the methanol/import issues, see our companion page on whether hand sanitizer requires FDA registration.

3. What are the three submissions, in order?

First, establishment registration: the facility's SPL, with its DUNS/FEI, operations, and - for foreign facilities - a U.S. Agent. Second, the labeler code form: an SPL that requests the labeler code identifying your firm (the first part of the NDC). Third, the product listing: the SPL for the specific hand sanitizer, with its NDC, active ingredient and strength, dosage form, package description, and labeling. They build on each other, so order matters.

4. What goes in the hand sanitizer product listing (SPL)?

The listing SPL captures the product's structured data: the active ingredient and its strength (e.g., "Ethyl alcohol 70% v/v") with its unique ingredient identifier, the dosage form and route, inactive ingredients, the package/NDC configuration, and the content of labeling (the Drug Facts panel and a labeling image). All of it has to be coded to FDA's controlled vocabularies and match the label - mismatches cause the listing to be rejected.

5. Does the listing depend on the registration?

Yes - that dependency is the key thing to get right. The product listing references your establishment (by DUNS/FEI) and your labeler code (the first segment of the NDC), so both must exist and be active before the listing will validate. Trying to list a product before the establishment is registered and the labeler code is assigned - or with a DUNS that doesn't match - is a leading cause of listing rejections.

6. Which active ingredients can I use?

For a monograph hand sanitizer, only three actives are eligible: ethyl alcohol (ethanol), isopropyl alcohol, and benzalkonium chloride. Twenty-eight others (including triclosan) are not eligible and would require an NDA. Your listing must reflect an eligible active at a permitted strength. We cover the eligible-ingredient rules in detail on the companion classification page - here the point is that the listing has to declare a compliant active.

7. Do foreign hand sanitizer facilities register the same way?

Yes, with one addition: a foreign establishment must designate a U.S. Agent (21 CFR 207.69) as part of the establishment registration. The rest of the workflow - labeler code, product listing, Drug Facts label, cGMP - is the same. The U.S. Agent must consent, and its designation is part of a valid registration, so it needs to be in place for the listing to stand on a valid foundation.

8. What is a labeler code and why do I need it first?

The labeler code identifies the firm marketing the product and forms the first segment of the NDC. You request it via its own SPL submission, and FDA assigns it. You need it before the product listing, because the listing's NDC is built on the labeler code. Sequencing it first avoids a listing that can't validate for lack of a labeler code.

9. What label does the listing require?

A compliant Drug Facts panel (21 CFR 201.66): active ingredient and strength, purpose (antiseptic), use, warnings (flammable, external use only, do not use in eyes, keep out of reach of children, do not ingest), directions, and inactive ingredients. The labeling in the SPL listing must match the physical label. Because hand sanitizer's warnings are specific, the label is a common failure point - review it before submitting.

10. Is there a fee, and does the registration renew?

Yes to both. OTC monograph drug manufacturers - including hand sanitizer makers - pay the annual OMUFA facility fee. And drug establishment registration renews annually, October–December (21 CFR 207.29), with drug listings kept current. A lapse makes the product misbranded and can inactivate the listing, so the workflow includes maintenance, not just the initial submissions.

11. What if my hand sanitizer listing gets rejected?

Read FDA's validation acknowledgment - it names the specific errors. Common ones are a labeler-code/DUNS mismatch, an establishment that isn't registered, document-tracking or structured-data errors (dosage form, active strength), and labeling that doesn't match the SPL. Fix every error, confirm the registration and labeler code are in place, re-validate, and resubmit. We have a dedicated guide to fixing a rejected drug listing.

12. Does cGMP apply to hand sanitizer?

Yes. As an OTC drug, hand sanitizer must be made under cGMP (21 CFR 210/211), which underpins consistent alcohol potency and testing to rule out methanol and other contaminants. The registration/listing workflow assumes the product is made under cGMP; a product that isn't is adulterated regardless of a clean listing.

13. How long does registration and listing take?

It depends on how ready the inputs are - DUNS/FEI, the eligible active and formula, the Drug Facts label, and (for foreign firms) the U.S. Agent. The SPL submissions themselves are electronic and validated by FDA; the time-consuming part is usually getting the label and product data right so the listing validates on the first attempt rather than bouncing. Preparing everything before submitting is the way to avoid a rejection cycle.

14. Does registration and listing mean my hand sanitizer is FDA-approved?

No. Registration identifies the facility, listing identifies the product, and monograph compliance lets you market without an NDA - but none of these is FDA "approval." Claiming a hand sanitizer is "FDA-approved" because it's registered or listed is misbranding. It's compliance, not approval.

15. Can I do the registration and listing myself?

You can - SPL is submitted through FDA tools like CDER Direct - but the three submissions, their sequence and dependencies, the controlled vocabularies, and the Drug Facts label are technical, and first-timers often hit repeated rejections. If you want it validated on the first pass, or you're a foreign firm coordinating the U.S. Agent consent, expert handling is usually faster overall.

16. How does FDA Registration Assistance handle hand sanitizer registration & listing?

We run the whole workflow: establishment registration (with U.S. Agent for foreign firms), the labeler code, and the NDC product listing in SPL, with the active/strength, Drug Facts label, and package data coded correctly so it validates - plus cGMP and OMUFA guidance and annual renewal. If a prior listing was rejected, we diagnose and fix it. We're an independent compliance firm serving 1,000+ companies across 135+ countries with 15+ years of experience. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.

HM
Reviewed By Hector Matos, Senior Regulatory Compliance Specialist  ·  15+ years FDA compliance experience  ·  Updated July 2026
Food and Drug Administration Contact Us for Assistance